FDA Approved: CARISOPRODOL — Supplemental Application (Rising Pharma Holdings, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for carisoprodol by Rising Pharma Holdings, Inc., enabling the generic product to be marketed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Muscle Spasm
• Musculoskeletal Conditions

Drugs mentioned

• Carisoprodol (Carisoprodol)

Snippet

SUPPL AP for CARISOPRODOL (CARISOPRODOL)